These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 26239619)
21. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. Dhandapani KM; Mahesh VB; Brann DW J Neurochem; 2007 Jul; 102(2):522-38. PubMed ID: 17596214 [TBL] [Abstract][Full Text] [Related]
22. miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma. She X; Yu Z; Cui Y; Lei Q; Wang Z; Xu G; Xiang J; Wu M; Li G Oncol Rep; 2014 Sep; 32(3):957-64. PubMed ID: 25017996 [TBL] [Abstract][Full Text] [Related]
23. Curcumin suppressed anti-apoptotic signals and activated cysteine proteases for apoptosis in human malignant glioblastoma U87MG cells. Karmakar S; Banik NL; Ray SK Neurochem Res; 2007 Dec; 32(12):2103-13. PubMed ID: 17562168 [TBL] [Abstract][Full Text] [Related]
24. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Shi L; Chen J; Yang J; Pan T; Zhang S; Wang Z Brain Res; 2010 Sep; 1352():255-64. PubMed ID: 20633539 [TBL] [Abstract][Full Text] [Related]
25. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells. Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM. Stojcheva N; Schechtmann G; Sass S; Roth P; Florea AM; Stefanski A; Stühler K; Wolter M; Müller NS; Theis FJ; Weller M; Reifenberger G; Happold C Oncotarget; 2016 Mar; 7(11):12937-50. PubMed ID: 26887050 [TBL] [Abstract][Full Text] [Related]
27. BC3EE2,9B, a synthetic carbazole derivative, upregulates autophagy and synergistically sensitizes human GBM8901 glioblastoma cells to temozolomide. Chen CM; Syu JP; Way TD; Huang LJ; Kuo SC; Lin CT; Lin CL Int J Mol Med; 2015 Nov; 36(5):1244-52. PubMed ID: 26329365 [TBL] [Abstract][Full Text] [Related]
28. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. Kunnumakkara AB; Diagaradjane P; Anand P; Harikumar KB; Deorukhkar A; Gelovani J; Guha S; Krishnan S; Aggarwal BB Int J Cancer; 2009 Nov; 125(9):2187-97. PubMed ID: 19623659 [TBL] [Abstract][Full Text] [Related]
29. MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis. Yang CH; Wang Y; Sims M; Cai C; He P; Yue J; Cheng J; Boop FA; Pfeffer SR; Pfeffer LM Oncotarget; 2016 Dec; 7(51):84017-84029. PubMed ID: 27705947 [TBL] [Abstract][Full Text] [Related]
30. miR‑146b‑5p suppresses glioblastoma cell resistance to temozolomide through targeting TRAF6. Qian Z; Zhou S; Zhou Z; Yang X; Que S; Lan J; Qiu Y; Lin Y Oncol Rep; 2017 Nov; 38(5):2941-2950. PubMed ID: 29048680 [TBL] [Abstract][Full Text] [Related]
31. HDAC6 promotes cell proliferation and confers resistance to temozolomide in glioblastoma. Wang Z; Hu P; Tang F; Lian H; Chen X; Zhang Y; He X; Liu W; Xie C Cancer Lett; 2016 Aug; 379(1):134-42. PubMed ID: 27267806 [TBL] [Abstract][Full Text] [Related]
33. Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function. Chen L; Li X; Liu L; Yu B; Xue Y; Liu Y Oncol Rep; 2015 Mar; 33(3):1465-74. PubMed ID: 25585997 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-146a promotes gastric cancer cell apoptosis by targeting transforming growth factor β-activated kinase 1. Chen Y; Zhou B; Xu L; Fan H; Xie J; Wang D Mol Med Rep; 2017 Jul; 16(1):755-763. PubMed ID: 28560435 [TBL] [Abstract][Full Text] [Related]
35. The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma. Zanotto-Filho A; Braganhol E; Edelweiss MI; Behr GA; Zanin R; Schröder R; Simões-Pires A; Battastini AM; Moreira JC J Nutr Biochem; 2012 Jun; 23(6):591-601. PubMed ID: 21775121 [TBL] [Abstract][Full Text] [Related]
36. Low-Dose DMC Significantly Enhances the Effect of TMZ on Glioma Cells by Targeting Multiple Signaling Pathways Both In Vivo and In Vitro. Shi L; Sun G Neuromolecular Med; 2015 Dec; 17(4):431-42. PubMed ID: 26458914 [TBL] [Abstract][Full Text] [Related]
37. Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling. Pyko IV; Nakada M; Sabit H; Teng L; Furuyama N; Hayashi Y; Kawakami K; Minamoto T; Fedulau AS; Hamada J Carcinogenesis; 2013 Oct; 34(10):2206-17. PubMed ID: 23715499 [TBL] [Abstract][Full Text] [Related]
38. TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance. Loftus JC; Dhruv H; Tuncali S; Kloss J; Yang Z; Schumacher CA; Cao B; Williams BO; Eschbacher JM; Ross JT; Tran NL Mol Cancer Res; 2013 Aug; 11(8):865-74. PubMed ID: 23699535 [TBL] [Abstract][Full Text] [Related]